Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Multimodality Therapy before and after Surgery in Patients with Squamous Cell Carcinoma of the Head and Neck


This phase II clinical trial studies how well multimodality therapy works before and after surgery in patients with squamous cell carcinoma of the head and neck. Immunotherapy with monoclonal antibodies, such as durvalumab, may induce changes in body’s immune system and may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as carboplatin, nab-paclitaxel, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving carboplatin, nab-paclitaxel, and durvalumab before surgery and using durvalumab with or without radiation therapy and cisplatin after surgery may kill more tumor cells in patients with head and neck cancer.
Gibson, Mike

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: